Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

11 Feb 2021 07:00

RNS Number : 6888O
Checkit PLC
11 February 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

 

11 February 2021

 

Checkit plc

("Checkit" or the "Group")

 

Trading update

 

The Group provides a trading update for the financial year ended 31 January 2021. A summary of the Group's unaudited revenue is as follows:

 

REVENUES (UNAUDITED) (£m)

Three months to

Twelve months to

 

 

 

31 Jan

2021 Actual

31 Jan

2020 Actual

Change

%

31 Jan

2021 Actual

31 Jan

2020 Actual

31 Jan 2020

Normalised*

Change Normalised*

%

Checkit Connect:

Recurring

1.5

1.0

+51%

5.1

3.2

3.9

+33%

Non-recurring

0.2

0.6

(54) %

1.6

1.6

2.1

(23) %

Total Checkit Connect

1.7

1.6

+6%

6.7

4.8

6.0

+13%

Total Checkit BEMS

1.7

1.6

+2%

6.5

5.0

6.8

(5) %

  Non - recurring

Total Group

3.4

3.2

+6%

13.2

9.8

12.8

+3%

 

* Normalised sales illustrate sales that would have been included in the Group's financial results had Checkit UK Limited, which was acquired on 14 May 2019, been owned by the Group throughout both periods.

 

The business performed above the Board's expectations during Q4.

 

The Board believes that the Group's operating result for FY21 will be around 15% better than current market estimates (prior to any adjustment related to prior year re-statement).

 

Checkit Connect recurring revenues for Q4 grew 51% compared to the same period in the prior year, and closed FY21 at £5.1m (+33% compared to prior year).

 

Annual recurring revenue (ARR) grew by 46% to close at £5.7m (FY20 £3.9m), reflecting the increase in annualised contracted Revenues achieved during the year.

 

These results are in line with trends announced previously and reflect a combination of additional subscribers, price increases and a continued programme of converting existing maintenance contracts to subscription-based income during the year.

 

Checkit Connect non-recurring revenue declined compared to FY20 due to the conversion of maintenance contracts to subscription income, timing differences on Q4 Healthcare installations due to the UK's national roll out of the COVID-19 vaccine program and H1 pandemic related field service challenges.

 

Checkit BEMS experienced a stabilisation of its revenue in Q4 as construction activity returned following the challenges of COVID-19 restrictions in H1. The business unit saw a revenue decline of 5% in FY21 due to the pandemic related challenges in the first half of the year.

 

Cash

Cash as of 31 January 2021 was £11.5m (31 January 2020: £14.3m; 31 July 2020: £13.4m).

 

 

Outlook

Following the announcement on 4 February 2021 regarding the acquisition of Tutela LLC and recruitment of two key senior hires, the Board is accelerating its growth plans in both Europe and in the US. This includes increasing investment in sales and marketing in FY22 designed to maximise subscriber volumes on the back of digital transformation trends which the Board believes will serve to accelerate ARR growth.

 

Restatement of prior year financial statements

Following the qualified Audit opinion in FY20, the Board revisited the assumptions made regarding its decision to fully impair the intangible assets in the FY20 financial statements due to the unforeseen impact of COVID-19.

In light of the resilient business performance, the group carried out a thorough impairment review of all balances related to the qualified audit opinion. From the work performed the Board has agreed with its auditors Grant Thornton that an adjustment should be made to restate FY20 financial statements.

The adjustment will result in an increase in intangible assets carried forward at 31 January 2020 and a reduction in the reported operating loss from continued operations. The full impact of restatement will be shared as part of the preliminary results announcement expected to be issued on 29 April 2021. These are non-cash accounting entries and so will have no effect on underlying profitability or cash position of the Group.

Forward looking statements

This document contains forward looking statements with respect to the business, strategy and plans of Checkit plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Checkit or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Checkit's actual future results may differ materially from the results expressed or implied in these forward-looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. The forward-looking statements contained in this document are made as of the date hereof, and Checkit undertakes no obligation to update any of its forward-looking statements.

 

 Checkit plc +44 (0) 1223 371000

 www.checkit.net

 Keith Daley (Executive Chair)

 Aylsa Muir (Chief Financial Officer)

 

 N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000

 Shaun Dobson / George Tzimas (Corporate Finance)

 Rachel Hayes (Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVBLFFFLLXBBV
Date   Source Headline
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company
20th Apr 20162:54 pmRNSDerivative Claim - Update
22nd Feb 20167:00 amRNSTrading Update
26th Jan 20167:00 amRNSDirectorate Change
20th Jan 20163:22 pmRNSHolding(s) in Company
25th Nov 20157:00 amRNSProduct Launch
24th Nov 20153:21 pmRNSHolding(s) in Company
10th Nov 20157:00 amRNSTrading Update
19th Oct 20153:41 pmRNSDerivative Claim - Update
5th Oct 20157:00 amRNSProduct Launch
28th Sep 20157:00 amRNSDirector's Dealing
14th Sep 20154:12 pmRNSDirector's dealing
10th Sep 20157:00 amRNSDirectorate Changes
10th Sep 20157:00 amRNSHalf Yearly Report
30th Jul 20154:45 pmRNSResult of AGM
23rd Jul 20159:00 amRNSTrading Update
22nd Jul 20157:00 amRNSDerivative claim - update
16th Jul 20154:09 pmRNSDerivative Claim - Update
8th Jul 20153:16 pmRNSLapse of Options
6th Jul 20153:49 pmRNSNotice of AGM
26th Jun 20154:00 pmRNSHolding(s) in Company
18th Jun 20158:50 amRNSDerivative Claim - Update
12th Jun 20154:42 pmRNSAnnual Report and Financial Statements
30th Apr 20157:00 amRNSFinal Results
27th Apr 20155:35 pmRNSHolding(s) in Company
7th Apr 20151:41 pmRNSHolding(s) in Company
12th Feb 20157:00 amRNSYear end trading update
28th Jan 201512:45 pmRNSDerivative Claim - Further Update
24th Nov 20147:00 amRNSTrading update
2nd Oct 20147:00 amRNSDerivative Claim - Update
31st Jul 20146:06 pmRNSResult of AGM
31st Jul 20147:00 amRNSAGM Statement
25th Jul 201411:15 amRNSDirector/PDMR Shareholding
17th Jul 201412:15 pmRNSResult of Open Offer
9th Jul 20148:00 amRNSNotice of AGM
25th Jun 20145:42 pmRNSHolding(s) in Company
23rd Jun 20147:00 amRNSPlacing and Proposed Open Offer
23rd Jun 20147:00 amRNSUnaudited full year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.